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was not the case in our study. Genetic differences in cir-
culating CHIKV lineages could also explain poor testing 
performance. Furthermore, the OnSite Chikungunya IgM 
Combo CE POC test uses a recombinant antigen covering 
the 226 residues of the E1 gene from CHIKV variant A226; 
recent studies on CHIKV protein characterization showed 
that more sensitive serologic assays can be obtained using 
specific early-phase E2 glycoprotein as antigens (3). 
The successful use of rapid immunochromatography-
based assays with monoclonal antibodies to detect viral 
diseases (e.g., dengue) has encouraged the development of 
rapid immunoassays for CHIKV antigens, and preliminary 
results for these assays seem promising (6). External qual-
ity assessment programs for POC tests and quality controls 
consisting of standardized positive serum could also be 
helpful for improving the performance of diagnostic tests.
In conclusion, returning travelers are sentinels of the 
rapidly changing epidemiology of CHIKV; thus, they re-
quire a prompt diagnosis and careful surveillance for their 
possible role in subsequent autochthonous disease trans-
mission. Implementation of user-friendly, rapid, and easily 
deliverable POC tests for a prompt and accurate laboratory 
diagnosis is therefore needed to improve patient manage-
ment and disease control measures.
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To the Editor: Circular replication initiation protein 
(Rep)–encoding single-stranded DNA (ssDNA) (CRESS-
DNA) genomes are found in diverse group II virus fami-
lies, which all possess a conserved Rep-encoding gene 
and a nonenveloped icosahedral capsid, except gemini-
viruses, which have twinned particles (1). Gemycircu-
larvirus (GcV) were initially discovered in fungi, but a 
growing number of new species has been characterized 
by metagenomics in air, sewage, insects, and feces from 
a broad range of vertebrates (1–5). GcVs have also been 
found in the brain and serum of humans with multiple 
sclerosis; in the cerebrospinal fluid of a patient with en-
cephalitis; and in several blood samples, including those 
from an HIV-positive blood donor (6–8). We report the 
presence of 2 divergent GcVs and a novel CRESS-DNA 
virus (CV) in 2 pericardial fluid samples from a patient 
with idiopathic recurrent pericarditis.
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The patient, a 14-year-old girl who had thoracic sco-
liosis surgery in 2007, was admitted to the hospital in 2009 
for pleuropneumonia and pericarditis, which required peri-
cardial drainage twice within 3 weeks (samples PF1 and 
PF2, respectively). She had thrombocytopenia, a leukocyte 
count within the normal range, and a high C-reactive protein 
level. Biochemical and cytologic testing, bacterial cultures, 
and PCR of pericardial fluid samples for cytomegalovirus, 
varicella zoster and herpes simplex viruses, parvovirus 
B19, fungal 18S rRNA, bacterial 16S rRNA, and Myco-
bacterium tuberculosis were negative. Upon approval from 
the Institut Fédératif de Recherche IFR48 Ethics Commit-
tee (Marseille, France) and written informed consent from 
the patient’s parents, we submitted the drainage samples for 
further investigation.
Virus particles in 0.45-μm filtrates were purified and 
analyzed by metagenomics as described (9); resulting con-
tigs were aligned against the National Center for Biotech-
nology Information nonredundant protein database using 
blastx (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Three con-
tigs were of viral origin (viral first hit, E-value ≤1E-03), all 
belonging to the ssDNA circular viruses. We obtained com-
plete genomic sequences by PCR with ad hoc primer pairs 
and Sanger sequencing technology (online Technical Ap-
pendix Table, http://wwwnc.cdc.gov/EID/article/22/10/16-
0052-Techapp1.pdf).
We annotated genomes using GeneMark (heuris-
tic parameters; http://exon.gatech.edu/GeneMark/) and 
EMBOSS palindrome (http://emboss.bioinformatics.nl/
cgi-bin/emboss/palindrome). Analysis of PF1 enabled 
characterization of HV-GcV1 (GenBank accession no. 
KU343136) (Figure). This genome displayed a typical 
GcV architecture, with a 2,264-nt circular DNA molecule 
carrying a capsid gene on 1 strand and 2 genes on the op-
posite strand, which coded for Rep1 (involved in replica-
tion initiation) and Rep2 (involved in replication termina-
tion), respectively. A putative hairpin structure showed a 
nanonucleotide motif, which was thought to be the Rep 
target, TAATGTTAT. A fourth gene with no homologs 
in databases was predicted upstream of the capsid gene. 
Phylogenetic inference from concatenated Rep placed this 
virus close to another GcV (found in sewage) in a clade 
comprising 2 other human-associated GcVs (online Tech-
nical Appendix Figure 1).
PF2 contained 2 other viruses: HV-GcV2 (GenBank ac-
cession no. KU343137), another GcV, and HV-CV1 (Gen-
Bank accession no. KU343138), a novel CRESS-DNA vi-
rus. HV-GcV2 (2,262 nt) shares the same stem-loop motif 
and genomic structure with HV-GcV1, with the exception 
of the rep gene, which is coded by a single open reading 
frame. HV-GcV2 proteins share low sequence similarity 
with HV-GcV1 proteins (33% for capsid and 46% for Rep, 
as determined by blastp [https://blast.ncbi.nlm.nih.gov/
Blast.cgi]). HV-GcV2 belongs to another clade of the phy-
logenetic tree that also contains sewage- and bird feces–as-
sociated viruses (online Technical Appendix Figure 1). HV-
CV1 (2,951 nt) possesses characteristics of CRESS-DNA 
genomes. Phylogenetic analysis of REP sequences showed 
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Figure. Genomic features of gemycircularviruses HV-GcV1 and 
HV-GcV2 and of a novel circular single-stranded DNA (ssDNA) 
virus, HV-CV1, including hairpin structure and predicted open 
reading frames. Cap, capsid; Hyp, hypothetical protein with 
unknown function; Rep, replication initiation protein.
that HV-CV1 and its closest homologue, an ssDNA circular 
virus of unknown taxon discovered in an Antarctic shelf 
pond, are distantly related to other CRESS-DNA viruses 
(online Technical Appendix Figure 2). HV-GcV2 and HV-
CV1 displayed no capsid protein similarity between them 
or with any other virus, as determined by blastp. Annota-
tion of the HV-CV1 capsid gene required use of HHBlits 
(https://toolkit.tuebingen.mpg.de/hhblits), a more sensitive 
algorithm (E-value 1.2E-06, probability of 97.2%).
PCR confirmed the absence of HV-GcV1 in PF2 and 
HV-GcV2 and HV-CV1 in PF1, suggesting multiple infec-
tions before each pericarditis event or a rapid fluctuation 
in the load of all 3 persisting viruses. An additional blastx 
search on 53 other virus metagenomes sequenced from 
pericardial fluids after pericarditis events failed to retrieve 
these sequences. To exclude the possibility of sample con-
tamination during procedures, we simultaneously treated a 
sample with the same reagents and kits used for PF1 and 
PF2 and surveyed it by PCR; results were negative. All 
metagenomes are publically available in the METAVIR 
(http://metavir-meb.univ-bpclermont.fr) directory under 
the pericardial fluids heading.
No relationship between these viruses and pericarditis 
was established. However, the fact that some CRESS-DNA 
viruses are animal pathogens (10) and the growing number of 
GcVs found in human samples in pathologic contexts (6,7) 
indicate that the viral genomes described here might repli-
cate in human cells, possibly as opportunistic pathogens (8). 
On the other hand, although diagnostic tests ruled out fungal 
or bacterial infections, we should still consider the possibil-
ity that these viruses infect other uncharacterized organisms. 
The genomes described here will assist further studies of the 
prevalence of these viruses in human populations.
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To the Editor: Japanese encephalitis (JE) is caused 
by a virus transmitted by Culex tritaeniorhynchus mos-
quitoes. JE was the major public health concern in South 
Korea until the late 1960s, with several thousand cases 
reported annually. The national vaccination program with 
the inactivated mouse brain–derived Nakayama strain was 
initiated in 1983 and targeted children <15 years of age. 
During 1983–2000, annual booster vaccinations were giv-
en to children <15 years of age, but in 2000, the booster 
schedule was changed to 2 doses (1 dose each) for children 
6 and 12 years of age. The live attenuated JE vaccine SA 
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